Day: January 14, 2022

Vivera Pharmaceuticals Issues Statement Regarding LuSys Laboratories Covid-19 Tests

Vivera Pharmaceuticals is highly discouraged to read the latest FDA safety communication that erroneously lists Vivera Pharmaceuticals as a brand of LuSys Laboratories or as a distributor of the LuSys Eagle Diagnostics test. While Vivera did work with LuSys Laboratories in mid-2020, the scope of that engagement was limited to development of a United States […]

Facebook Youtube Instagram Linkedin
Copyright © 2024 Vivera Pharmaceuticals, Inc. All rights reserved.
This information – including product information – is intended only for certified clinicians in the United States. The products discussed herein may have different labeling in different countries. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.